Results 31 to 40 of about 18,009 (296)

Sensitive Voltammetric Determination of Ticlopidine in Pharmaceuticals Employing a Multi-Walled Carbon Nanotubes Paste Electrode

Orbital: The Electronic Journal of Chemistry, 2016
A sensitive analytical procedure has been developed for the determination of ticlopidine using a multi-walled carbon nanotubes paste electrode (MWCNTsPE). Direct oxidation of analyte was observed by cyclic voltammetry as evidenced by the presence of well-
Igor Rebech, Jessica Scremin, César Ricardo Teixeira Tarley, Elen Romão Sartori   +3 more
doaj   +3 more sources

Highly productive and scalable approach to synthesize ticlopidine: A potent thienopyridine anti-platelet aggregation drug

Heliyon, 2020
Ticlopidine (trade name Ticlid), an acidic thienopyridine derivative, is an effective, well-known and long-acting inhibitor of platelet aggregation.
Muhammad Faisal, Quret ul Aein, Aamer Saeed, Amara Mumtaz, Fayaz Ali Larik   +4 more
doaj   +1 more source

Detecting Adverse Drug Events Through the Chronological Relationship Between the Medication Period and the Presence of Adverse Reactions From Electronic Medical Record Systems: Observational Study

JMIR Medical Informatics, 2021
BackgroundMedicines may cause various adverse reactions. An enormous amount of money and effort is spent investigating adverse drug events (ADEs) in clinical trials and postmarketing surveillance.
Kei Teramoto, Toshihiro Takeda, Naoki Mihara, Yoshie Shimai, Shirou Manabe, Shigeki Kuwata, Hiroshi Kondoh, Yasushi Matsumura   +7 more
doaj   +1 more source

Pharmacokinetics of Ticlopidine in the Rabbit

Journal of Pharmacy and Pharmacology, 1999
Abstract There is no information about the pharmacokinetics of ticlopidine in rabbits. Such information is valuable in designing appropriate dosing regimens for experimental studies of the drug with ultimate applications in man. The disposition kinetics of ticlopidine at three dose levels were evaluated in three groups of six rabbits ...
Francois Vallee, Pamela R. Tessier, Cyprian O. Onyeji, Charles H. Nightingale, David P. Nicolau   +4 more
openaire   +3 more sources

Drugs for preventing red blood cell dehydration in people with sickle cell disease. [PDF]

, 2016
BACKGROUND: Sickle cell disease is an inherited disorder of hemoglobin, resulting in abnormal red blood cells. These are rigid and may block blood vessels leading to acute painful crises and other complications.
Ballas, Samir K., Nagalla, Srikanth
core   +2 more sources

A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis [PDF]

, 2003
Background Intimal hyperplasia and resulting restenosis limit the efficacy of coronary stenting. We studied a coronary stent coated with the antiproliferative agent paclitaxel as a means of preventing restenosis.
Choi, D, Ho, DSW, Hong, MK, Jang, Y, Lam, R, Lee, CW, Mintz, GS, Park, SJ, Park, SW, Raizner, AE, Shim, WH, Weissman, NJ   +11 more
core   +1 more source

Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report

Journal of Medical Case Reports, 2010
Introduction Ticlopidine is a platelet inhibitor used to prevent thrombosis in patients with cerebrovascular or coronary artery disease. The most common side effects are mild and transitory: diarrhea, dyspepsia, nausea and rashes.
Previtera Antonino M, Pagani Rossella
doaj   +1 more source

The effect of antiaggregational therapy on the long-term patency of the femoropopliteal/crural bypass [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2012
Introduction. Antiaggregational therapy can reduce thrombosis development following the arterial reconstruction surgery. In most cases acetylsalicylic acid and ticlopidine are used as antiaggregational agents. Objective.
Vasić Dragan, Radmili Oliver, Davidović Lazar, Vraneš Milica   +3 more
doaj   +1 more source

The FDA Has Ended Required Blood Monitoring for Clozapine Use-Will This Impact the Management of Parkinson's Disease Psychosis? [PDF]

Mov Disord
Movement Disorders, Volume 40, Issue 9, Page 1821-1825, September 2025.
Weintraub D, Schoen I.
europepmc   +2 more sources

Cilostazol reduces restenosis after carotid artery stenting [PDF]

, 2010
BACKGROUND: Although carotid artery stenting (CAS) has been proposed as an alternative to carotid endarterectomy in cerebral revascularization, restenosis remains an unsolved issue.
Hayakawa Mikito, Matsumaru Yuji, Matsumura Akira, Nemoto Shigeru, Takigawa Tomoji, 松村 明, 滝川 知司   +6 more
core   +1 more source